Page: 11 of 30 7 8 9 10 11 12 13 14 15

Dr Jeffrey Infante - Sarah Cannon Research Institute, USA Channel: www.ecancer.tv Length: 0 Date: July 22, 2010 Dr Infante discusses the work the Sarah Cannon Research Institute does and the benefits the launch of the UK programme will bring. He discusses the...

Dr Prof Jonathan Ledermann - UCL Cancer Institute, UK Channel: www.ecancer.tv Length: 0 Date: July 22, 2010 Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses researc...

Dr Giampaolo Merlini, University of Pavia, Italy Channel: www.ecancer.tv Length: 0 Date: July 22, 2010 Dr Merlini talks at ASCO about amyloidosis and the importance of its early diagnosis and the symptoms such as protein in urine and cardiology issue...

Prof Danilo Perrotti - The Ohio State University, USA Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Perrotti speaks about the discovery that microRNA can be used to bind to proteins and block their function. Initial results suggest this could...

Prof Wendy Parulekar - Queen’s University, Canada Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Parulekar speaks about the NCIC and the interim results of their study, carried out in partnership with the UK Medical Research Council, into...

Professor Alan Burnett – Cardiff University, UK Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Burnett speaks about research into the treatment of AML presented at the 2010 EHA congress. The topics include developments with immunoconjuga...

Prof Gary Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Schwartz discusses the use of targeted therapy to treat sarcomas. Imatinib has been shown to reduce recurrence rates and has traditionally bee...

Dr Christoph Thomssen - Martin-Luther University, Halle, Germany Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Dr Thomssen discusses the difficulties faced when developing personalised medicine and the importance of prognostic and predictive markers in this ...

Prof Jean-Charles Soria - Institut Gustave Roussy, Paris, France Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Dr Soria speaks about locally advanced non-small cell lung cancer and the importance of personalised therapy. The development of drugs such as criz...

Professor Hilary Calvert – University College London, UK Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Calvert speaks about his current work at UCL developing phase I and translational research in addition to working with the UCL bioscience depa...

Prof John Wagstaff – University of Swansea, Wales Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Wagstaff speaks about his highlights from the 2010 ASCO conference. These include the extremely positive results of a trial investigating ipil...

Prof George Demetri - Harvard Medical School, USA Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Demetri describes two key presentations from ASCO 2010: the rapid progress made developing a therapy for ALK mutation related non-small cell l...

Dr Susanne Briest - University of Leipzig, Germany Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Dr Briest talks about results from ASCO 2010 that will influence the way breast cancer is treated. These include research into the relationship bet...

Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Eggermont talks about the significance of ipilimumab. This monoclonal antibody, although developed to treat melanoma, could have important im...

Prof Heinz Zwierzina - Innsbruck Medical University, Austria Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Zwierzina discusses the Biotherapy Development Association (BDA), a group that brings together pre-clinical and clinical scientists in order ...

Prof Michael Baumann - University of Technology, Dresden, Germany Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Michael Baumann, president of ECCO, discusses an ECCO ASCO joint symposium that will take place at all future ECCO and ASCO conferences. Prof...

Prof Matti Aapro - Clinique de Genolier in Genolier, Switzerland Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Aapro speaks about the difficulties of treating cancer in elderly patients. When treating elderly cancer patients clinicians must consider a n...

Dr Silvia Marsoni - Mario Negri Institute, Milan, Italy and Prof Filippo de Braud - European Institute of Oncology, Milan, Italy Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Dr Silvia Marsoni and Prof Filippo de Braud discuss the key research that has stood out from ASCO 2010, including PI3K, ERK, BRAF, MEK and TOR and...

Professor Stan Kaye – Institute of cancer Research, London, UK Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Kaye talks about the future of ovarian cancer research. One area that is expected to be very important is research targeting the VEGF protein....

Prof Malcolm Mason – Cardiff University, Wales Channel: www.ecancer.tv Length: 0 Date: July 20, 2010 Prof Mason speaks about the results of an inter-group trial conducted by the UK Medical Research Council in collaboration with the National Cancer ...

Page: 11 of 30 7 8 9 10 11 12 13 14 15